271 related articles for article (PubMed ID: 9331296)
1. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study.
DiGiuseppe JA; Louie DC; Williams JE; Miller DT; Griffin CA; Mann RB; Borowitz MJ
Am J Surg Pathol; 1997 Oct; 21(10):1223-30. PubMed ID: 9331296
[TBL] [Abstract][Full Text] [Related]
2. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
[TBL] [Abstract][Full Text] [Related]
3. Blastic natural killer cell leukemia/lymphoma presenting as overt leukemia.
Alvarez-Larrán A; Villamor N; Hernández-Boluda JC; Ferrer A; Camós M; Campo E; López-Guillermo A
Clin Lymphoma; 2001 Dec; 2(3):178-82; discussion 183-4. PubMed ID: 11779295
[TBL] [Abstract][Full Text] [Related]
4. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D
Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765
[TBL] [Abstract][Full Text] [Related]
5. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.
Suzuki R; Yamamoto K; Seto M; Kagami Y; Ogura M; Yatabe Y; Suchi T; Kodera Y; Morishima Y; Takahashi T; Saito H; Ueda R; Nakamura S
Blood; 1997 Sep; 90(6):2417-28. PubMed ID: 9310493
[TBL] [Abstract][Full Text] [Related]
6. Blastic CD4 NK cell leukemia/lymphoma: a distinct clinical entity.
Falcão RP; Garcia AB; Marques MG; Simões BP; Fonseca BA; Rodrigues ML; Foss NT
Leuk Res; 2002 Sep; 26(9):803-7. PubMed ID: 12127554
[TBL] [Abstract][Full Text] [Related]
7. Challenge in diagnosis of CD56+ lymphoproliferative disorders: two cases of CD56+CD33+ lymphoma/leukemia.
Yang X; Wasserman PG; Bhargava A; Iqbal U; Ragnauth S; Fuchs A
Arch Pathol Lab Med; 2004 Aug; 128(8):e100-3. PubMed ID: 15270596
[TBL] [Abstract][Full Text] [Related]
8. Blastoid NK cell leukemia/lymphoma with cutaneous involvement.
Ginarte M; Abalde MT; Peteiro C; Fraga M; Alonso N; Toribio J
Dermatology; 2000; 201(3):268-71. PubMed ID: 11096204
[TBL] [Abstract][Full Text] [Related]
9. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
Suzuki R; Nakamura S
Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell precursor acute lymphoma/leukemia presenting in an infant.
Natkunam Y; Cherry AM; Cornbleet PJ
Arch Pathol Lab Med; 2001 Mar; 125(3):413-8. PubMed ID: 11231495
[TBL] [Abstract][Full Text] [Related]
11. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
Chan JK; Sin VC; Wong KF; Ng CS; Tsang WY; Chan CH; Cheung MM; Lau WH
Blood; 1997 Jun; 89(12):4501-13. PubMed ID: 9192774
[TBL] [Abstract][Full Text] [Related]
12. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
13. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
14. Blastic natural killer cell lymphoma/leukemia: a report of seven cases.
Bayerl MG; Rakozy CK; Mohamed AN; Vo TD; Long M; Eilender D; Palutke M
Am J Clin Pathol; 2002 Jan; 117(1):41-50. PubMed ID: 11789729
[TBL] [Abstract][Full Text] [Related]
15. Uncommon cases of immature-type CD56+ natural killer (NK)-cell neoplasms, characterized by expression of myeloid antigen of blastic NK-cell lymphoma.
Owatari S; Otsuka M; Takeshita T; Mizukami K; Suzuki S; Uozumi K; Tashiro Y; Arima N; Hanada S
Int J Hematol; 2009 Mar; 89(2):188-194. PubMed ID: 19109730
[TBL] [Abstract][Full Text] [Related]
16. Monomorphic agranular natural killer cell lymphoma/leukemia with no Epstein-Barr virus association.
Matano S; Nakamura S; Nakamura S; Annen Y; Hattori N; Kobayashi K; Kyoda K; Sugimoto T
Acta Haematol; 1999; 101(4):206-8. PubMed ID: 10436303
[TBL] [Abstract][Full Text] [Related]
17. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
[TBL] [Abstract][Full Text] [Related]
18. Blastic NK-cell lymphoma/leukemia with T-cell receptor gamma rearrangement.
Aoyama Y; Yamane T; Hino M; Ohta K; Nakamae H; Yamamura R; Koh KR; Takubo T; Inoue T; Tatsumi Y; Tatsumi N
Ann Hematol; 2001 Dec; 80(12):752-4. PubMed ID: 11797118
[TBL] [Abstract][Full Text] [Related]
19. Pediatric acute blastic natural killer cell leukemia.
DuBois SG; Etzell JE; Matthay KK; Robbins E; Banerjee A
Leuk Lymphoma; 2002 Apr; 43(4):901-6. PubMed ID: 12153184
[TBL] [Abstract][Full Text] [Related]
20. Non-B, non-T neoplasms with lymphoblast morphology: further clarification and classification.
Karube K; Ohshima K; Tsuchiya T; Yamaguchi T; Suefuji H; Suzumiya J; Harada M; Kikuchi M
Am J Surg Pathol; 2003 Oct; 27(10):1366-74. PubMed ID: 14508398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
